Filing Analysis
Ultralife Corporation filed an 8-K to announce the release of its second quarter financial results for the period ended June 30, 2026. The filing serves as a formal notice that earnings data is being made public via a press release.
📋 Key Facts
- Report date: August 7, 2026
- Reporting period: Second quarter ended June 30, 2026
- The filing includes an attached press release (Exhibit 99.1) containing financial results.
- Signed by Philip A. Fain, Chief Financial Officer and Treasurer.
Ultralife Corporation held its 2026 Annual Meeting of Stockholders on July 22, 2026. The meeting resulted in the election of five directors and the ratification of WithumSmith+Brown, PC as the independent auditor.
📋 Key Facts
- Annual Meeting held on July 22, 2026.
- Quorum was met with 13,980,794 shares (83.93% of outstanding shares) represented in person or by proxy.
- Five directors were elected: Michael E. Manna, Janie Goddard, Thomas L. Saeli, Robert W. Shaw II, and Bradford T. Whitmore.
- WithumSmith+Brown, PC was ratified as the independent registered public accounting firm for 2026.
- Shareholders approved an advisory resolution on executive compensation.
- Shareholders voted in favor of a 3-year frequency for future advisory votes on executive compensation.
Ultralife Corporation (ULBI) reported its financial results for the first quarter ended March 31, 2026. The filing serves as a formal notice of the earnings release and includes the full press release as an exhibit.
📋 Key Facts
- The report was filed on May 8, 2026, covering the first quarter ended March 31, 2026.
- The filing was made under Item 2.02 (Results of Operations and Financial Condition).
- The press release detailing the financial performance is included as Exhibit 99.1.
- The report was signed by Philip A. Fain, Chief Financial Officer and Treasurer.
Ultralife Corporation (ULBI) announced its financial results for the fourth quarter ended December 31, 2025. The disclosure was made via a press release issued on March 10, 2026, and filed under Item 2.02.
📋 Key Facts
- Released Q4 2025 financial results on March 10, 2026
- Reporting period ended December 31, 2025
- Filed under Item 2.02 (Results of Operations and Financial Condition)
- Exhibit 99.1 contains the full press release
Ultralife Corporation filed an 8-K to announce the release of its third quarter financial results for the period ended September 30, 2025. The filing serves as a formal notification that earnings data is being made public via press release.
📋 Key Facts
- Report date: November 18, 2025
- Reporting period: Third quarter ended September 30, 2025
- The company issued a press release (Exhibit 99.1) containing the financial results.
- Signed by Philip A. Fain, Chief Financial Officer and Treasurer.
Ultralife Corporation announced the replacement of its independent auditor, Freed Maxick P.C., with Withum Smith+Brown, PC, effective August 22, 2025. The change is driven by Withum's acquisition of certain assets from the outgoing firm.
🚩 Red Flags
- Material weakness in internal control over financial reporting identified in the FY2024 audit.
- Auditor change (even if triggered by M&A activity) often requires scrutiny regarding the transition of complex accounting issues.
📋 Key Facts
- Effective date of auditor replacement: August 22, 2025.
- Outgoing auditor: Freed Maxick P.C. (FM).
- Incoming auditor: Withum Smith+Brown, PC (Withum).
- Reason for change: Acquisition of certain assets of FM by Withum.
- The previous auditor's reports for FY2023 and FY2024 did not contain adverse or qualified opinions regarding financial statements.
- Internal control warning: The 2024 audit report expressed an opinion that the Company did not maintain effective internal control over financial reporting due to a material weakness.
Ultralife Corporation filed an 8-K to announce the release of its financial results for the second quarter ended June 30, 2025. The filing serves as a formal notification that earnings data is being made public via a press release.
📋 Key Facts
- Report date: August 7, 2025
- Reporting period: Second Quarter ended June 30, 2025
- The filing includes an attachment (Exhibit 99.1) containing the press release of financial results.
- Signed by Philip A. Fain, Chief Financial Officer and Treasurer.
Ultralife Corporation held its 2025 Annual Meeting of Stockholders on July 16, 2025. The meeting resulted in the election of five directors and the ratification of Freed Maxick P.C. as the company's independent registered public accounting firm.
📋 Key Facts
- Annual Meeting held on July 16, 2025.
- Quorum was met with 85.35% of outstanding shares (14,196,720 shares) present in person or by proxy.
- Five directors were elected: Michael E. Manna, Janie Goddard, Thomas L. Saeli, Robert W. Shaw II, and Bradford T. Whitmore.
- Stockholders ratified Freed Maxick P.C. as the independent registered public accounting firm for 2025 with 14,042,572 votes in favor.
Ultralife Corporation filed an 8-K to announce the release of its financial results for the first quarter ended March 31, 2025. The filing serves as a formal notice that a press release containing these results was issued on May 9, 2025.
📋 Key Facts
- Reporting period: First Quarter ended March 31, 2025.
- Filing date: May 9, 2025.
- The company issued a press release (Exhibit 99.1) containing financial results and operations updates.
Ultralife Corporation issued an 8-K to announce the release of its financial results for the fourth quarter and full fiscal year ended December 31, 2024. The filing serves as a formal notification that the company's earnings press release is being made public.
📋 Key Facts
- Financial results for Q4 and Full Year 2024 were released on April 1, 2025.
- The reporting period ended December 31, 2024.
- The filing includes an earnings press release as Exhibit 99.1.
Ultralife Corporation filed an amendment to its previous 8-K to include audited financial statements and pro forma information regarding its acquisition of Electrochem Solutions, Inc. This filing fulfills the reporting requirements for the transaction completed on October 31, 2024.
🚩 Red Flags
- None identified in this specific amendment; it is a compliance filing for an acquisition.
📋 Key Facts
- The filing is an Amendment (8-K/A) to a previously filed report from November 6, 2024.
- Ultralife Corporation acquired Electrochem Solutions, Inc. on October 31, 2024.
- Includes audited combined financial statements of Electrochem as of December 31, 2023 (Exhibit 99.2).
- Includes unaudited combined financial statements for the nine-month period ended September 27, 2024 (Exhibit 99.3).
- Provides unaudited pro forma combined financial information as of September 30, 2024 (Exhibit 99.4).
Ultralife Corporation filed an 8-K to announce the release of its financial results for the third quarter ended September 30, 2024. The filing serves as a formal notification that a press release containing these results was issued on November 8, 2024.
📋 Key Facts
- Reporting period: Third Quarter ended September 30, 2024.
- Filing date: November 8, 2024.
- The filing includes a press release as Exhibit 99.1 regarding financial results.
Ultralife Corporation completed the $50 million acquisition of Electrochem Solutions, Inc. from Greatbatch Ltd. on October 31, 2024. To fund this acquisition and refinance existing debt, the company entered into a new $55 million senior secured term loan facility with KeyBank National Association.
🚩 Red Flags
- Increased leverage: The company took on $55 million in new secured debt to fund the acquisition and refinance old debt.
- Variable interest rate risk: Interest rates are tied to benchmarks plus a margin determined by the leverage ratio.
- Restrictive covenants: The company must maintain specific senior leverage ratios (3.00x - 3.50x) or face default.
📋 Key Facts
- Acquisition of Electrochem Solutions, Inc. for a purchase price of $50 million (subject to working capital/net cash adjustments).
- New Credit Agreement includes a 5-year, $55 million senior secured term loan with KeyBank National Association.
- Term Loan Facility repayment schedule: quarterly installments starting March 31, 2025, maturing October 31, 2029.
- The acquisition was funded via the proceeds of the new Term Loan Facility.
- New credit agreement includes a revolving credit facility with availability based on trade receivables and inventories.
- Financial covenants include a consolidated senior leverage ratio that steps down from 3.50x to 3.00x through 2027.
Ultralife Corporation entered into a definitive agreement to acquire Electrochem Solutions, Inc. from Greatbatch Ltd. for $50 million in cash. The transaction is expected to close by the end of October 2024 and will be funded through amended credit facilities.
🚩 Red Flags
- The acquisition is debt-funded via credit facility amendments, which may increase the company's leverage ratio.
📋 Key Facts
- Acquisition price: $50 million (subject to working capital adjustments).
- Target company: Electrochem Solutions, Inc., a Massachusetts corporation.
- Seller: Greatbatch Ltd. (a subsidiary of Integer Holdings Corporation).
- Funding source: Borrowings under credit facilities currently being amended with the primary lender.
- Closing timeline: Expected by end of October 2024.
- Risk mitigation: Buyer-side representation and warranty insurance policy, costs shared equally between Company and Seller.
Ultralife Corporation filed an 8-K to announce the release of its second quarter financial results for the period ended June 30, 2024. The filing serves as a formal announcement of the press release containing these earnings figures.
📋 Key Facts
- The report date is July 25, 2024.
- Financial results pertain to the second quarter ended June 30, 2024.
- The filing includes a press release as Exhibit 99.1.
Ultralife Corporation held its 2024 Annual Meeting of Stockholders on July 16, 2024. The meeting resulted in the election of five directors and the ratification of Freed Maxick CPAs, P.C. as the independent auditor.
🚩 Red Flags
- Significant broker non-votes (2,535,628 shares) across all director elections and the incentive plan vote.
📋 Key Facts
- Annual Meeting held on July 16, 2024; quorum was met with 81.68% of shares present (13,577,184 shares).
- Five directors were elected: Michael E. Manna, Janie Goddard, Thomas L. Saeli, Robert W. Shaw II, and Bradford T. Whitmore.
- Stockholders ratified Freed Maxick CPAs, P.C. as the independent registered public accounting firm for 2024 with 13,474,791 votes in favor.
- The Ultralife Corporation 2024 Long-Term Incentive Plan was approved by shareholders.
- A shareholder proposal to elect directors by majority vote was defeated (3,313,138 for vs. 7,607,272 against).
Ultralife Corporation filed an 8-K to announce the release of its financial results for the first quarter ended March 31, 2024. The filing serves as a formal notice that earnings data is available via press release.
📋 Key Facts
- Report covers the first quarter ended March 31, 2024.
- Financial results were released via press release on April 25, 2024.
- The filing includes Exhibit 99.1 containing the press release.
Ultralife Corporation issued an 8-K to announce the release of its financial results for the fourth quarter and full fiscal year ended December 31, 2023.
📋 Key Facts
- Report date: February 15, 2024
- Reporting period: Fourth quarter and full year ended December 31, 2023
- The filing serves as a formal announcement of the release of earnings results via press release (Exhibit 99.1).